| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.751 | 10.465 | 25.152 | 42.909 | 29.901 | 9.828 | 10.372 | 8.337 |
| Total Income - EUR | - | - | 1.751 | 10.466 | 25.152 | 42.909 | 29.901 | 9.828 | 10.372 | 8.337 |
| Total Expenses - EUR | - | - | 1.497 | 1.218 | 8.097 | 17.388 | 19.428 | 9.300 | 8.246 | 5.296 |
| Gross Profit/Loss - EUR | - | - | 254 | 9.247 | 17.056 | 25.521 | 10.473 | 528 | 2.126 | 3.041 |
| Net Profit/Loss - EUR | - | - | 201 | 8.933 | 16.804 | 25.113 | 9.948 | 239 | 1.533 | 2.437 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Kolbau Hemacons Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 17.753 | 13.110 | 9.194 | 4.556 | 2.307 | 367 |
| Current Assets | - | - | 385 | 9.635 | 8.867 | 32.211 | 8.459 | 1.762 | 4.680 | 3.220 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 1.130 | 105 | 4.273 | 3.164 | 1.755 | 1.927 | 1.566 |
| Cash | - | - | 385 | 8.505 | 8.762 | 27.939 | 5.295 | 8 | 2.753 | 1.655 |
| Shareholders Funds | - | - | 377 | 9.303 | 25.927 | 44.728 | 17.509 | 5.679 | 6.646 | 2.708 |
| Social Capital | - | - | 175 | 172 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | - | - | 9 | 332 | 1.105 | 594 | 144 | 639 | 342 | 879 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Kolbau Hemacons Srl